Placeholder Banner

BIO Statement: BIO Urges FDA Release of Risk Assessment on Animal Cloning

March 10, 2016

Dear Ms. Tipton, Mr. Kozak and Mr. Suber:

On behalf of the Biotechnology Industry Organization (BIO), I urge the International Dairy Foods Association, the National Milk Products Federation and U.S. Dairy Export Council and their members to join BIO in supporting the U.S. Food and Drug Administration's (FDA's) release of its final risk assessment, which we anticipate will appropriately confirm the safety of livestock cloning. We ask you to join us in encouraging its release as soon as possible.

The new animal tracking program announced today by two of BIO's members, ViaGen and Trans Ova Genetics, is another great step by our industry that will help locate and track animal clones in teh food chain to provide additional information related to associated food products. These efforts will promote a wider variety of choices for th world's food supply, while facilitating smooth trade transactions in the agricultural community and helping to support the legitimate marketing claims.

Download Full Comments Below
Read the letter
Discover More
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a…
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology…